This is from the latest quarterly:
Own Brand Update:
Administrative delays in the Australian Therapeutic Goods Administration (TGA) granting a Good Manufacturing Practice (GMP) certificate to the U.S. manufacturer of VESIsorb® has affected the launch timeline for the Avani Rapid CBD capsules. Although the TGA has not provided specific timing guidance, ECS anticipates the launch to occur in Q3 FY24, with production commencing post-certification. ECS’ RAP veterans’ brand is steadily growing, delivering 86% increase compared to the prior quarter.
Soap Box, page-286
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.61M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $114.3K | 7.133M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 1714893 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 595616 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.6¢ | 1.6¢ | 1.6¢ | 1879554 | ||
| Last updated 15.42pm 06/06/2024 ? | |||||
| ECS (ASX) Chart |